These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1505603)

  • 1. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects.
    Molinaro M; Villani P; Regazzi MB; Rondanelli R; Doveri G
    Eur J Clin Pharmacol; 1992; 43(1):105-7. PubMed ID: 1505603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].
    Veyssier P; Fourtillan JB; Modai J; Couet W; Lefebvre MA; Darchis JP; Vincent Du Laurier M; Bryskier A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):596-9. PubMed ID: 3534750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of ofloxacin administered orally in elderly subjects with bronchial or urinary tract infections].
    Bardin C; Clavier M; Darchis JP; Chauvin M; Veyssier P; Farinotti R
    Therapie; 1992; 47(1):35-9. PubMed ID: 1523592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacokinetics of oral ofloxacin formulations in normal subjects.
    Stein GE; LeBel M; Flor SC; Zinny M
    Curr Med Res Opin; 1991; 12(8):479-84. PubMed ID: 1764952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models.
    Rademaker CM; Jones RW; Notarianni LJ; van Dijk A; Glerum JH; Verhoef J
    Pharm Weekbl Sci; 1989 Dec; 11(6):224-8. PubMed ID: 2616254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers.
    Agarwal S; Solomon WD; Gowda KV; Selvan PS; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK
    Arzneimittelforschung; 2007; 57(10):679-83. PubMed ID: 18074762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.
    Yuk JH; Nightingale CH; Quintiliani R; Sweeney KR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):384-6. PubMed ID: 2024973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis.
    Orlando R; Sawadogo A; Miglioli PA; Cappellazzo MG; Palatini P
    Chemotherapy; 1992; 38(1):1-6. PubMed ID: 1617997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.
    Farinotti R; Trouvin JH; Bocquet V; Vermerie N; Carbon C
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1590-2. PubMed ID: 3190187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D; Borner K; Pustelnik A
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.
    Yuen GJ; Drusano GL; Brooks J; Flor S
    Pharmacotherapy; 1992; 12(2):88-92. PubMed ID: 1570232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.
    Chien SC; Chow AT; Natarajan J; Williams RR; Wong FA; Rogge MC; Nayak RK
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1562-5. PubMed ID: 9210685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gender on the pharmacokinetics of ofloxacin.
    Sowinski KM; Abel SR; Clark WR; Mueller BA
    Pharmacotherapy; 1999 Apr; 19(4):442-6. PubMed ID: 10212016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.